Silver Lake Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Buy
1,364
+2
+0.1% +$2.03K 0.5% 55
2025
Q4
$1.46M Buy
1,362
+2
+0.1% +$1.91K 0.57% 54
2025
Q3
$1.04M Sell
1,360
-191
-12% -$142K 0.41% 59
2025
Q2
$1.21M Sell
1,551
-49
-3% -$38.1K 0.51% 57
2025
Q1
$1.32M Buy
1,600
+2
+0.1% +$1.66K 0.58% 56
2024
Q4
$1.23M Sell
1,598
-39
-2% -$32.3K 0.54% 56
2024
Q3
$1.45M Sell
1,637
-16
-1% -$14.4K 0.59% 55
2024
Q2
$1.5M Sell
1,653
-28
-2% -$22.4K 0.67% 51
2024
Q1
$1.31M Buy
+1,681
New +$1.2M 0.58% 52
2023
Q3
Sell
-1,698
Closed -$796K 76
2023
Q2
$796K Buy
1,698
+2
+0.1% +$839 0.43% 56
2023
Q1
$582K Buy
+1,696
New +$572K 0.32% 59
2022
Q4
Sell
-1,692
Closed -$547K 76
2022
Q3
$547K Buy
1,692
+2
+0.1% +$634 0.32% 64
2022
Q2
$548K Buy
1,690
+2
+0.1% +$600 0.3% 64
2022
Q1
$483K Buy
1,688
+2
+0.1% +$515 0.23% 74
2021
Q4
$466K Buy
1,686
+2
+0.1% +$507 0.22% 81
2021
Q3
$389K Buy
1,684
+3
+0.2% +$740 0.19% 87
2021
Q2
$430K Buy
1,681
+2
+0.1% +$402 0.21% 79
2021
Q1
$314K Buy
1,679
+3
+0.2% +$587 0.16% 84
2020
Q4
$283K Buy
1,676
+3
+0.2% +$448 0.15% 82
2020
Q3
$248K Buy
1,673
+3
+0.2% +$464 0.15% 82
2020
Q2
$274K Buy
1,670
+3
+0.2% +$460 0.18% 74
2020
Q1
$231K Buy
1,667
+3
+0.2% +$412 0.17% 77
2019
Q4
$219K Buy
+1,664
New +$193K 0.13% 79
2019
Q2
Sell
-1,654
Closed -$215K 83
2019
Q1
$215K Sell
1,654
-849
-34% -$103K 0.15% 81
2018
Q4
$290K Buy
2,503
+5
+0.2% +$559 0.22% 73
2018
Q3
$268K Buy
2,498
+32
+1% +$3.2K 0.16% 83
2018
Q2
$203K Buy
+2,466
New +$203K 0.16% 77
2018
Q1
Sell
-2,482
Closed -$210K 85
2017
Q4
$210K Buy
2,482
+5
+0.2% +$425 0.15% 85
2017
Q3
$212K Buy
2,477
+11
+0.4% +$902 0.16% 81
2017
Q2
$203K Buy
2,466
+9
+0.4% +$734 0.15% 83
2017
Q1
$207K Sell
2,457
-275
-10% -$22K 0.16% 80
2016
Q4
$201K Buy
2,732
+10
+0.4% +$745 0.16% 80
2016
Q3
$218K Buy
2,722
+9
+0.3% +$720 0.16% 78
2016
Q2
$214K Buy
+2,713
New +$204K 0.16% 78
2016
Q1
Sell
-2,697
Closed -$227K 68
2015
Q4
$227K Buy
2,697
+9
+0.3% +$747 0.2% 65
2015
Q3
$225K Buy
2,688
+10
+0.4% +$844 0.2% 68
2015
Q2
$224K Buy
+2,678
New +$204K 0.18% 75

Other funds holding LLY

Silver Lake Advisory's LLY Position: Q1 2026 in Review

Silver Lake Advisory increased its Eli Lilly (LLY) stake by 0.15% in Q1 2026, buying an estimated $2.03K and bringing the position to 1,364 shares worth $1.25M. The position accounts for 0.5% of the portfolio, ranked #55.

Silver Lake Advisory first reported a position in LLY in Q2 2015 and has held it in 37 quarters since. The position peaked at $1.5M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Silver Lake Advisory held 1,364 shares of Eli Lilly worth $1.25M as of Q1 2026.
  • Silver Lake Advisory bought 2 Eli Lilly shares in Q1 2026, an estimated $2.03K.
  • Eli Lilly made up 0.5% of Silver Lake Advisory's portfolio in Q1 2026, its #55 holding.
  • Silver Lake Advisory first reported a position in Eli Lilly in Q2 2015 and has held it in 37 quarters since.
  • Silver Lake Advisory's Eli Lilly position peaked at $1.5M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Silver Lake Advisory's 13F filing for Q1 2026, filed 27 Apr 2026.